Slovenia is making strides in the cannabis industry with a proposed medical cannabis law that is projected to boost the market by 4% annually, reaching over €55 million by 2029. Now, Slovenia joins France as the most recent European country to propose medical cannabis reform. The proposed bill aims to provide patients with access to medical cannabis products while also creating a regulatory framework that promotes transparency and quality control.
The team at the International Cannabis Business Conference recently received this groundbreaking information. With the new proposed legislation for medical cannabis in Slovenia, they have positioned themselves to become a key player in the global cannabis market. Slovenia aims to establish a benchmark for ethical medical cannabis production and distribution.
This new proposal will legalize cannabis in Slovenia for both medical and scientific purposes. The proposed legislation permits the cultivation, manufacture, distribution, and use of cannabis for medicinal and scientific objectives within a regulated and supervised framework. Furthermore, THC and cannabis, including plant matter and extracts, will no longer be listed as prohibited substances in Slovenia.
Under the new proposal, all products shall undergo stringent quality control during and post-production to safeguard patients. Medical cannabis in Slovenia must be cultivated and processed according to GACP, GMP, and European Pharmacopoeia standards to ensure patient safety and quality. The law also ensures that there will be a stable and continuous supply of cannabis through pharmacies, licensed wholesalers, and healthcare providers. Lawmakers anticipate that the legislation will prevent patients from relying on imports or experiencing irregular access.
In line with international law and European practices, the proposed legislation for medical cannabis in Slovenia aligns with UN drug conventions and draws inspiration from successful models in countries like Germany, the Netherlands, Austria, and the Czech Republic. This ensures legal sufficiency and international compatibility for Slovenia’s burgeoning cannabis industry.
As Slovenia moves forward with its plans to legalize medical cannabis, it joins a growing number of European countries that are recognizing the potential benefits of this emerging industry. Just last month, France proposed to legalize the medical use of cannabis, signaling a shift in attitudes toward its therapeutic properties. This trend suggests that more countries may follow suit in the near future, opening up new opportunities for research and development in the medical cannabis industry across Europe.
With the potential for significant economic growth and job creation, the proposed medical cannabis law has garnered support from various stakeholders in Slovenia and beyond. Advocates believe that this legislation will not only benefit patients in need of alternative treatments but also boost the country’s economy through increased exports and domestic production.
The post Proposed Legislation For Medical Cannabis in Slovenia appeared first on AudioKush.